Elevated pro-inflammatory CD4+CD28- lymphocytes and stroke recurrence and death.

Z G Nadareishvili1, H Li, V Wright

  • 1Stroke Branch, National Institute of Neurologic Disorders and Stroke, NIH, 10 Center Dr., Bethesda, MD 20892-1294, USA.

Neurology
|October 27, 2004
PubMed
Summary

Elevated counts of CD4+CD28- T-cells in the blood indicate a higher risk of recurrent stroke or death after an initial ischemic stroke. This finding suggests a potential biomarker for stroke outcomes.